
Lakia J. Jackson-tongue
Examiner (ID: 2679, Phone: (571)272-2921 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 887 |
| Issued Applications | 525 |
| Pending Applications | 105 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11921579
[patent_doc_number] => 09789140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Probiotic recolonisation therapy'
[patent_app_type] => utility
[patent_app_number] => 15/260879
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6185
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260879
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260879 | Probiotic recolonisation therapy | Sep 8, 2016 | Issued |
Array
(
[id] => 14535153
[patent_doc_number] => 20190203198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => METHOD FOR CONVERTING GENOME SEQUENCE OF GRAM-POSITIVE BACTERIUM BY SPECIFICALLY CONVERTING NUCLEIC ACID BASE OF TARGETED DNA SEQUENCE, AND MOLECULAR COMPLEX USED IN SAME
[patent_app_type] => utility
[patent_app_number] => 15/757243
[patent_app_country] => US
[patent_app_date] => 2016-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15757243
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/757243 | Method for converting genome sequence of gram-positive bacterium by specifically converting nucleic acid base of targeted DNA sequence, and molecular complex used in same | Sep 8, 2016 | Issued |
Array
(
[id] => 13675187
[patent_doc_number] => 20160376327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => Fusobacterium polypeptides and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/259880
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14858
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15259880
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/259880 | Fusobacterium polypeptides and methods of use | Sep 7, 2016 | Issued |
Array
(
[id] => 11684077
[patent_doc_number] => 09682108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Probiotic recolonisation therapy'
[patent_app_type] => utility
[patent_app_number] => 15/260207
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6386
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15260207
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/260207 | Probiotic recolonisation therapy | Sep 7, 2016 | Issued |
Array
(
[id] => 13672665
[patent_doc_number] => 20160375066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => PROBIOTIC RECOLONISATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/258811
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5716
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258811 | Probiotic recolonisation therapy | Sep 6, 2016 | Issued |
Array
(
[id] => 13014251
[patent_doc_number] => 10030234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Modified gram positive bacteria and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/258433
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 11
[patent_no_of_words] => 22254
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258433
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258433 | Modified gram positive bacteria and uses thereof | Sep 6, 2016 | Issued |
Array
(
[id] => 11348914
[patent_doc_number] => 20160367654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS'
[patent_app_type] => utility
[patent_app_number] => 15/251308
[patent_app_country] => US
[patent_app_date] => 2016-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50107
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15251308
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/251308 | Immunogenic compositions comprising | Aug 29, 2016 | Issued |
Array
(
[id] => 11457117
[patent_doc_number] => 20170051023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'VACCINE'
[patent_app_type] => utility
[patent_app_number] => 15/243409
[patent_app_country] => US
[patent_app_date] => 2016-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10250
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15243409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/243409 | Vaccine | Aug 21, 2016 | Issued |
Array
(
[id] => 11324941
[patent_doc_number] => 20160355554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'Fusobacterium polypeptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 15/243469
[patent_app_country] => US
[patent_app_date] => 2016-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15511
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15243469
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/243469 | Fusobacterium polypeptides and methods of use | Aug 21, 2016 | Abandoned |
Array
(
[id] => 13367301
[patent_doc_number] => 20180235191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => FORMULATIONS AND METHODS FOR PROMOTING HONEYBEE HEALTH
[patent_app_type] => utility
[patent_app_number] => 15/753899
[patent_app_country] => US
[patent_app_date] => 2016-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753899
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753899 | Formulations and methods for promoting honeybee health | Aug 17, 2016 | Issued |
Array
(
[id] => 15468603
[patent_doc_number] => 10550164
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 15/749214
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20187
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749214
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/749214 | None | Aug 2, 2016 | Issued |
Array
(
[id] => 13354689
[patent_doc_number] => 20180228884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => VACCINE CONTAINING INACTIVATED CELLS OF STAPHYLOCOCCUS AUREUS MIXED WITH LEUCOCIDIN
[patent_app_type] => utility
[patent_app_number] => 15/751123
[patent_app_country] => US
[patent_app_date] => 2016-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751123
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751123 | Vaccine containing inactivated cells of | Jul 28, 2016 | Issued |
Array
(
[id] => 14403785
[patent_doc_number] => 20190167736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => BACTERIOPHAGE FOR TREATING STAPHYLOCOCCUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 15/746663
[patent_app_country] => US
[patent_app_date] => 2016-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746663
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746663 | BACTERIOPHAGE FOR TREATING STAPHYLOCOCCUS INFECTIONS | Jul 24, 2016 | Abandoned |
Array
(
[id] => 13325983
[patent_doc_number] => 20180214529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => EDIBLE VACCINATION AGAINST MICROBIAL PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 15/747252
[patent_app_country] => US
[patent_app_date] => 2016-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15747252
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/747252 | Edible vaccination against microbial pathogens | Jul 21, 2016 | Issued |
Array
(
[id] => 13867625
[patent_doc_number] => 20190030153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => MYCOPLASMA VACCINES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/746770
[patent_app_country] => US
[patent_app_date] => 2016-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15746770
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/746770 | MYCOPLASMA VACCINES AND USES THEREOF | Jul 21, 2016 | Abandoned |
Array
(
[id] => 13354625
[patent_doc_number] => 20180228852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => COMPOSITION CONTAINING EXTRACELLULAR POLYSACCHARIDE PRODUCED BY CERIPORIA LACERATA AS ACTIVE INGREDIENT FOR IMMUNOREGULATION
[patent_app_type] => utility
[patent_app_number] => 15/751516
[patent_app_country] => US
[patent_app_date] => 2016-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751516
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751516 | Composition containing extracellular polysaccharide produced by ceriporia lacerata as active ingredient for immunoregulation | Jul 21, 2016 | Issued |
Array
(
[id] => 13314283
[patent_doc_number] => 20180208678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => METHODS AND COMPOSITION FOR MODIFYING ENZYMES
[patent_app_type] => utility
[patent_app_number] => 15/745496
[patent_app_country] => US
[patent_app_date] => 2016-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745496
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745496 | Methods and composition for modifying enzymes | Jul 14, 2016 | Issued |
Array
(
[id] => 13425113
[patent_doc_number] => 20180264099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => LIVE ATTENUATED ORAL VACCINE AGAINST SHIGELLOSIS AND TYPHOID FEVER
[patent_app_type] => utility
[patent_app_number] => 15/742459
[patent_app_country] => US
[patent_app_date] => 2016-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742459
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742459 | Live attenuated oral vaccine against shigellosis and typhoid fever | Jul 5, 2016 | Issued |
Array
(
[id] => 11421329
[patent_doc_number] => 20170029472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A'
[patent_app_type] => utility
[patent_app_number] => 15/197952
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 27866
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15197952
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/197952 | Fusion proteins and combination vaccines comprising | Jun 29, 2016 | Issued |
Array
(
[id] => 16275598
[patent_doc_number] => 10758605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Compositions and methods for treating cancer and promoting wound healing
[patent_app_type] => utility
[patent_app_number] => 15/740622
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 108
[patent_no_of_words] => 28554
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15740622
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/740622 | Compositions and methods for treating cancer and promoting wound healing | Jun 28, 2016 | Issued |